RGD Reference Report - Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Glucocorticosteroids inhibit mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 in human airway inflammation with eosinophilia.

Authors: Jahnsen, FL  Haye, R  Gran, E  Brandtzaeg, P  Johansen, FE 
Citation: Jahnsen FL, etal., J Immunol. 1999 Aug 1;163(3):1545-51.
RGD ID: 4145448
Pubmed: PMID:10415058   (View Abstract at PubMed)

How eosinophils are preferentially recruited to inflammatory sites remains elusive, but increasing evidence suggests that chemokines that bind to the CCR3 participate in this process. In this study, we investigated the transcript levels and chemotactic activity of CCR3-binding chemokines in nasal polyps, a disorder often showing prominent eosinophilia. We found that mRNA expression for eotaxin, eotaxin-2, and monocyte-chemotactic protein-4 was significantly increased in nasal polyps compared with turbinate mucosa from the same patients, or histologically normal nasal mucosa from control subjects. Interestingly, the novel CCR3-specific chemokine, eotaxin-2, showed the highest transcript levels. Consistent with these mRNA data, polyp tissue fluid exhibited strong chemotactic activity for eosinophils that was significantly inhibited by a blocking Ab against CCR3. When patients were treated systemically with glucocorticosteroids, the mRNA levels in the polyps were reduced to that found in turbinate mucosa for all chemokines. Together, these findings suggested an important role for CCR3-binding chemokines in eosinophil recruitment to nasal polyps. Such chemokines, therefore, most likely contribute significantly in the pathogenesis of eosinophil-related disorders; and the reduced chemokine expression observed after steroid treatment might reflect, at least in part, how steroids inhibit tissue accumulation of eosinophils.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
Nasal Polyps  IEP 4145448; 4145448mRNA:increased expression:nasal cavity epitheliumRGD 
Nasal Polyps  ISOCCL11 (Homo sapiens)4145448; 4145448mRNA:increased expression:nasal cavity epitheliumRGD 
Nasal Polyps  ISOCCL24 (Homo sapiens)4145448; 4145448mRNA:increased expression:nasal cavity epitheliumRGD 

Objects Annotated

Genes (Rattus norvegicus)
Ccl11  (C-C motif chemokine ligand 11)
Ccl24  (C-C motif chemokine ligand 24)

Genes (Mus musculus)
Ccl11  (C-C motif chemokine ligand 11)
Ccl24  (C-C motif chemokine ligand 24)

Genes (Homo sapiens)
CCL11  (C-C motif chemokine ligand 11)
CCL24  (C-C motif chemokine ligand 24)


Additional Information